Ubs Asset Management Americas Inc Legend Biotech Corp Transaction History
Ubs Asset Management Americas Inc
- $345 Billion
- Q2 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Legend Biotech Corp stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 106,533 shares of LEGN stock, worth $5.23 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
106,533
Previous 330,323
67.75%
Holding current value
$5.23 Million
Previous $18.5 Million
74.53%
% of portfolio
0.0%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding LEGN
# of Institutions
199Shares Held
74.2MCall Options Held
374KPut Options Held
387K-
Price T Rowe Associates Inc Baltimore, MD11.5MShares$564 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$368 Million5.01% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$326 Million7.6% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$281 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.77MShares$234 Million1.06% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $8.22B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...